... B, et al.: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup ...

... B, et al.: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup ...

... Refid: 326. Patient preference-based utility weights from the functional ... liver metastases treated by intraoperative radiofrequency ablation with or ...

... of GI SNs among their study participants than in the general population (95% CI, ... GI SN histology was adenocarcinoma (56%). The highest risk of GI SNs was ...

... of CRC.[ 630 , 631 ] Several studies show that the prevalence of colorectal adenocarcinoma in patients with formally defined criteria for SPS is ... Many of the genetic and histological alterations found in HPs of patients with ... adenocarcinoma. Sporadic serrated polyps are the precursors to CRCs ...

... had intraoperative rupture, and all patients were alive. Metastatic disease, usually in the liver, may occur in up to 15% of the cases.[ 2 - 6 ] Single-agent gemcitabine has been reported to be effective in cases of unresectable or metastatic disease.[ 10 ] References Rojas Y, Warneke CL, Dhamne ...

... 71, 1988. [ PubMed : 2841895 ] Hanna W, Kahn HJ: The ultrastructure of metastatic adenocarcinoma in serous fluids. An aid in identification of the primary site of the neoplasm. Acta Cytol 29 ( ...

... C, et al. Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas. Tumour Biol. 1992; 13 (1-2):18–26. [ ... monoclonal antibodies ) led to a correct diagnosis of the primary tissue of origin ... metastatic serous effusions. DiBonito et al. (1993) reported that ...